We Help Improve Lives in Hundreds of Ways
Learn more by:
Names, Facts, Figures about Bayer
Bayer is an innovation company with a more than 150-year history and core competencies in the fields of health care and agriculture. We develop new molecules for use in innovative products and solutions to improve the health of humans, animals and plants. Our research and development activities are based on a profound understanding of the biochemical processes in living organisms.
We are committed to operating sustainably and to addressing our social and ethical responsibilities as a corporate citizen, while at the same time respecting the interests of all our stakeholders. Employees with a passion for innovation will enjoy excellent development opportunities at Bayer.
All this is part of our mission: Bayer: Science For A Better Life
Focus on Life Science Businesses
Following the economic and legal separation of our MaterialScience business, now Covestro*, Bayer has charted the course for its successful development as a Life Science company. In this connection, we have realigned our corporate structure. Since January 1, 2016, Bayer’s core business has been managed by three divisions: Pharmaceuticals, Consumer Health and Crop Science. Animal Health is a separate reporting segment.
Our Life Science businesses hold leading positions in innovation-driven growth markets. Together they make up a strong, attractive and balanced portfolio that is resistant to fluctuations in demand and to potential risks. The previous structure comprising a strategic management holding company and operational subgroups has thus been replaced by an integrated organization under the umbrella of the strong Bayer brand.
Business operations are the responsibility of the divisions
Central Service Functions
Dual governance system with the following governance bodies:
|Board of Management:||Eight members.|
|Supervisory Board:||20 members, Chairman: Werner Wenning|
Best-selling Bayer products are:
In the health care field: Xarelto™, Kogenate™, Betaferon™/Betaseron™/Mirena product family , Nexavar™
The key brands in the agriculture field are: Confidor™ / Gaucho™, Nativo™ product family, Nunhems™, Basta™/ Liberty™, Prosaro™ product family
The Bayer Group comprises around 302 consolidated companies** in 75 countries throughout the world. Global headquarters are in Leverkusen, Germany.
** fully consolidated subsidiaries (as of Dec. 31, 2014)
On September 30, 2015, the Bayer Group had 102,168 employees worldwide.
Read more about Bayer employees
Jobs and Career
Bayer Stock included in nearly all the major share indices traded on all German stock exchanges dividend per share: EUR 2.25 (2014)
Bayer Group Key Data
(as of December 31, 2014)
* formerly Bayer MaterialScience more
With its broad range of iconic brands, Consumer Health aims to support people do more for their health and well-being. This not only increases personal quality of life but can also greatly reduce health care costs.
The rapid pace of change in global health care markets is characterized by an increasing trend toward consumer-centered health care. Consumer Health’s own rich history in the self-care arena began in 1899 with the introduction of Bayer’s flagship global consumer brand, Bayer Aspirin™.
Today, the division brings consumers some of the world’s best-known and most trusted over-the-counter (OTC) medications, nutritional supplements and other self-care products. The division’s balanced portfolio includes strong brands in all the categories in which it competes, including Allergy, Analgesics, Cardiovascular Risk Prevention, Cough & Cold, Dermatology, Foot Care, Gastrointestinals, Nutritionals and Sun Care.
|Over-the-counter (OTC) brands, nutritional supplements and other self-care products play a key role in help people to stay healthy.||The over-65s are the fastest-growing section of the population.|
|There is a crucial need to ensure healthy lives and promote well-being for all ages.||Pollen dispersal can be simulated in the allergy room at the Consumer Center in Memphis, Tennessee. Venkat Venkatakrishnan (right) monitors the pollen concentration in the room, which is designed for up to 12 people.|
The Consumer Health Division is a leader among the top consumer health care companies in the world. The division operates in more than 100 countries and maintains 18 manufacturing sites and four product research and development centers. The goal of Consumer Health is to further expand its strong position in the market aiming to lead the market in the countries and categories in which they compete. Key focus areas include driving forward the integration of the consumer care businesses acquired in 2014 from Merck & Co., Inc., and Dihon Pharmaceutical Group Co., Ltd. in China.
"At Consumer Health, we are working together to lead a global transformation – from treating illness to promoting wellness. We are working together to help every consumer we serve lead a better, healthier life through science-driven innovations that improve wellness, treat everyday ailments and prevent disease."
- Erica Mann, Member of the Board of Management of Bayer AG and Head of the Consumer Health Division
With more than 170 brands around the world and 17 OTC brands generating annual sales of more than €100 million each, the Consumer Health Division is well positioned to take advantage of the sustained growth forecast for the OTC market.
In fact, some of the world’s best-known and most trusted over-the-counter medications, nutritional supplements and other self-care products are part of the Consumer Care portfolio, including Alka Seltzer™, Aleve™, Aspirin™, Bepanthen™/Bepanthol™, Berocca™, Canesten™, Claritin™, Coppertone™, Dr. Scholl’s™, Elevit™, Iberogast™, MiraLAX™, One a Day™, Rennie™, Redoxon™ and Supradyn™.
- Find all information on Consumer Health at Bayer on www.consumerhealth.bayer.com
The Pharmaceuticals Division focuses on prescription products, especially for women’s healthcare and cardiology, and also on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The division also comprises the Radiology Business Unit which markets contrast-enhanced diagnostic imaging equipment together with the necessary contrast agents.
With our innovative products, we seek to achieve a significant therapeutic benefit for patients, while at the same time satisfying the growing requirements of physicians and health insurers.
In the medium term, our recently launched products such as Xarelto™, Eylea™, Stivarga™, Xofigo™ and Adempas™ in particular should contribute to increased sales. To safeguard our growth in the long term, we will be further expanding our early-stage research activities and driving forward the clinical development of active ingredient candidates discovered in-house. Moreover, we will continue to systematically supplement our development portfolio by means of licensing agreements and acquisitions.
- Find all information on Pharmaceuticals at Bayer on www.pharma.bayer.com